Zhende Medical Stock Hits Day Low of CNY 89 Amid Price Pressure

Zhende Medical Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.4% on May 25, 2026. The stock reached an intraday low of CNY 89.00, reflecting a challenging trading session. In terms of performance metrics, Zhende Medical's one-day performance contrasts sharply with the China Shanghai Composite, which gained 0.96%. Over the past week, the stock has decreased by 4.63%, while its monthly performance shows a slight decline of 0.94%. However, the company has demonstrated significant growth over the past year, boasting a remarkable 335.13% increase, far outpacing the Shanghai Composite's 24.02% rise. Despite these impressive annual gains, the company faces underlying financial pressures, including a negative trend in net sales and operating profit over the last five years. The current debt-equity ratio stands at a high 5.96%, indicating potential financial strain. With a market capitalization of CNY 24,444 million, Zhende Medical continues to navigate a complex market landscape amid these recent developments.